{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:18:54Z","timestamp":1791314334110,"version":"4.3.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,6]]},"DOI":"10.2106\/jbjs.j.01199","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T11:24:15Z","timestamp":1311333855000},"page":"1235-1242","source":"Crossref","is-referenced-by-count":84,"title":["Atypical Subtrochanteric Femoral Fractures in Patients with Skeletal Malignant Involvement Treated with Intravenous Bisphosphonates"],"prefix":"10.2106","volume":"93","author":[{"given":"Mark E.","family":"Puhaindran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeez","family":"Farooki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20210131","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"bib2-20210131","first-page":"349","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","year":"2007","journal-title":"J Bone Joint Surg Br."},{"key":"bib3-20210131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","year":"2008","journal-title":"Injury."},{"key":"bib4-20210131","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","article-title":"Case reports: two femoral insufficiency fractures after long-term alendronate therapy","volume":"467","year":"2009","journal-title":"Clin Orthop Relat Res."},{"key":"bib5-20210131","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","year":"2008","journal-title":"J Orthop Trauma."},{"key":"bib6-20210131","article-title":"Atraumatic bilateral femur fracture in long-term bisphosphonate use","volume":"32","year":"2009","journal-title":"Orthopedics."},{"key":"bib7-20210131","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.2106\/JBJS.H.01774","article-title":"Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy","volume":"91","year":"2009","journal-title":"J Bone Joint Surg Am."},{"key":"bib8-20210131","article-title":"Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures","year":"2010"},{"key":"bib9-20210131","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","year":"2001","journal-title":"Bone."},{"key":"bib10-20210131","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","article-title":"Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34)","volume":"17","year":"2002","journal-title":"J Bone Miner Res."},{"key":"bib11-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/17453670903139914","article-title":"Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate","volume":"80","year":"2009","journal-title":"Acta Orthop."},{"key":"bib12-20210131","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","year":"2009","journal-title":"J Bone Miner Res."},{"key":"bib13-20210131","first-page":"1761","article-title":"Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","year":"2010","journal-title":"N Engl J Med."},{"key":"bib14-20210131","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group","volume":"16","year":"1998","journal-title":"J Clin Oncol."},{"key":"bib15-20210131","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group","volume":"16","year":"1998","journal-title":"J Clin Oncol."},{"key":"bib16-20210131","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial","volume":"100","year":"2004","journal-title":"Cancer."},{"key":"bib17-20210131","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2006.07.3361","article-title":"Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer","volume":"25","year":"2007","journal-title":"J Clin Oncol."},{"key":"bib18-20210131","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","year":"1996","journal-title":"Lancet."},{"key":"bib19-20210131","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","year":"1998","journal-title":"JAMA."},{"key":"bib20-20210131","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","year":"2007","journal-title":"N Engl J Med."},{"key":"bib21-20210131","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","year":"2007","journal-title":"N Engl J Med."},{"key":"bib22-20210131","first-page":"48","article-title":"The importance of mechanical loading in bone biology and medicine","volume":"7","year":"2007","journal-title":"J Musculoskelet Neuronal Interact."},{"key":"bib23-20210131","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1359\/JBMR.050522","article-title":"Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases","volume":"20","year":"2005","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201107060-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:27:59Z","timestamp":1787750879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201107060-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.j.01199","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}